Home › NDC Lookup › RxCUI directory › RxCUI 1801278

{4 (0.8 ML adalimumab 50 MG/ML Auto-Injector [Humira]) } Pack [Humira Pen - Psoriasis Star... — RxCUI 1801278

RxNorm drug concept · Brand name pack
RxCUI 1801278 Brand name pack · BPCK ● Current RxNorm concept 9 FDA products 17 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1801278
Official name{4 (0.8 ML adalimumab 50 MG/ML Auto-Injector [Humira]) } Pack [Humira Pen - Psoriasis Starter Pack]
Concept typeBrand name pack (BPCK)
RxNorm statusCurrent RxNorm concept
Also known asHumira Psoriasis Starter Pack 40 MG/0.8 ML Pen (4 count); Humira Psoriasis/Uveitis Starter Pack 40 MG/0.8 ML Pen (4 count)
FDA products mapped9
Package NDCs mapped17
Reported Medicaid activity (SDUD)380,296 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Adalimumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Adalimumab is approved for quite a few inflammatory conditions — rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psor...
  • What conditions is adalimumab actually approved to treat?
  • You'll use either an autoinjector pen or a prefilled syringe, depending on what your doctor prescribes. Before injecting, take it out of the refrigerator and let it sit for 15 to 3...
  • How do I give myself this injection at home?
📖 Read our full Adalimumab Injection guide →

🕸️ Concept Web — How {4 (0.8 ML adalimumab 50 MG/ML Auto-Injector [Hu... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept {4 (0.8 ML adalimumab 50 MG/ML Auto-Injector [Humira]) } Pack [Humira Pen - Psoriasis Starter Pack] RxCUI 1801278

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Adalimumab 327361
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Humira 353484
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Adalimumab Auto-Injector 1655725
    • Adalimumab Injectable Product 1163691
    • Adalimumab Auto-Injector [Humira] 1655727
    • Humira Injectable Product 1171992
    • Pack 746839
    • Injectable Product 1151126
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 1

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 13 of 13 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

📦 FDA Products & Package NDCs

9 products · 17 package NDCs
17 package NDCs map to RxCUI 1801278 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00074-0124-01 1 KIT in 1 CARTON (0074-0124-01) / 1 KIT in 1 KIT * 1 SYRI... Humira AbbVie Inc. 2017-04-21
00074-0124-02 2 KIT in 1 CARTON (0074-0124-02) / 1 KIT in 1 KIT * 1 SYRI... Humira AbbVie Inc. 2020-12-16
00074-0124-03 3 KIT in 1 CARTON (0074-0124-03) / 1 KIT in 1 KIT * 1 SYRI... Humira AbbVie Inc. 2017-04-21
00074-0124-04 4 KIT in 1 CARTON (0074-0124-04) / 1 KIT in 1 KIT * 1 SYRI... Humira AbbVie Inc. 2021-02-24
00074-0124-74 1 KIT in 1 CARTON (0074-0124-74) / 1 KIT in 1 KIT * 1 SYRI... Humira AbbVie Inc. 2017-04-21
00074-0243-02 2 KIT in 1 CARTON (0074-0243-02) / 1 KIT in 1 KIT * 1 SYRI... Humira AbbVie Inc. 2015-11-23
00074-0554-01 1 KIT in 1 CARTON (0074-0554-01) / 1 KIT in 1 KIT * 1 SYRI... Humira AbbVie Inc. 2016-03-09
00074-0554-02 2 KIT in 1 CARTON (0074-0554-02) / 1 KIT in 1 KIT * 1 SYRI... Humira AbbVie Inc. 2016-03-09
00074-0554-71 2 KIT in 1 CARTON (0074-0554-71) / 1 KIT in 1 KIT * 1 SYRI... Humira AbbVie Inc. 2016-03-09
00074-0554-74 1 KIT in 1 CARTON (0074-0554-74) / 1 KIT in 1 KIT * 1 SYRI... Humira AbbVie Inc. 2016-03-09
00074-0616-02 2 KIT in 1 CARTON (0074-0616-02) / 1 KIT in 1 KIT * 1 SYRI... Humira AbbVie Inc. 2017-04-28
00074-0616-71 2 KIT in 1 CARTON (0074-0616-71) / 1 KIT in 1 KIT * 1 SYRI... Humira AbbVie Inc. 2017-04-28
00074-0817-02 2 KIT in 1 CARTON (0074-0817-02) / 1 KIT in 1 KIT * 1 SYRI... Humira AbbVie Inc. 2017-04-28
00074-1539-03 3 KIT in 1 CARTON (0074-1539-03) / 1 KIT in 1 KIT * 1 SYRI... Humira AbbVie Inc. 2017-04-21
00074-2540-01 1 KIT in 1 CARTON (0074-2540-01) / 1 KIT in 1 KIT * 1 mL i... Humira AbbVie Inc. 2016-10-17
00074-3799-02 2 KIT in 1 CARTON (0074-3799-02) / 1 KIT in 1 KIT * 1 SYRI... Humira AbbVie Inc. 2002-12-31
00074-4339-02 2 KIT in 1 CARTON (0074-4339-02) / 1 KIT in 1 KIT * 1 SYRI... Humira AbbVie Inc. 2006-06-23
Observed labelers: AbbVie Inc. (17) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.